XSHG
600673
Market cap17bUSD
Jul 10, Last price
37.15CNY
1D
-3.10%
1Q
18.24%
Name
Guangdong Hec Technology Holding Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangdong Hec Technologyholding Co., Ltd, established in 1993 and headquartered in Dongguan, China, is a diverse enterprise with significant operations in several key industrial domains. The company specializes in the creation and production of electronic new materials, various alloy materials, chemical products, and pharmaceuticals. Its extensive portfolio includes essential components for aluminum electrolytic capacitors, such as corrosion and chemical electrode foils, alongside the capacitors themselves. The company also produces soft magnetic materials, specialized foils like electronic light foil, hydrophilic foil, brazing foil, and battery aluminum foil. Within its chemical segment, offerings range from hydrochloric acid, caustic soda, and liquid chlorine to hydrogen peroxide, methane chloride, and eco-friendly refrigerants. Beyond materials and chemicals, Guangdong Hec is actively involved in the pharmaceutical sector. It engages in the research, development, and commercialization of medicinal products designed to address a wide array of health conditions. These include treatments for antiviral, endocrine, metabolic, anti-infective, cardiovascular, and cerebrovascular diseases, as well as solutions for viral influenza. The company's diverse range of products and solutions finds application across numerous industries. These encompass automotive heat exchangers, central air conditioning systems, chemical processing, food and paper production, pesticide manufacturing, electronic technology, chip fabrication, the photovoltaic industry, sewage treatment, and various disinfection and sterilization processes.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||